<?xml version="1.0" encoding="UTF-8"?>
<p class="p">The hydrocarbon chain of the emerging or supplied γ-linolenic acid under the influence of an elongase is elongated to dihomo-γ-linolenic acid (DGLA). The GLA elongation is faster than the desaturation of linoleic acid [
 <xref rid="B24-antioxidants-07-00108" ref-type="bibr" class="xref">24</xref>,
 <xref rid="B25-antioxidants-07-00108" ref-type="bibr" class="xref">25</xref>]. Dihomo-γ-linolenic acid is metabolized by cyclooxygenase (COX) to series 1 prostaglandins, which are eicosanoids with anti-inflammatory activity (see 
 <xref rid="antioxidants-07-00108-t005" ref-type="table" class="xref">Table 5</xref>) [
 <xref rid="B24-antioxidants-07-00108" ref-type="bibr" class="xref">24</xref>]. Under the influence of 15-lipoxygenase (15-LOX), DGLA is oxidized to 15-hydroxyeicosatrienoic (15-HETrE) acid, which has anti-inflammatory and anti-proliferative properties [
 <xref rid="B24-antioxidants-07-00108" ref-type="bibr" class="xref">24</xref>,
 <xref rid="B26-antioxidants-07-00108" ref-type="bibr" class="xref">26</xref>]. Therefore, increased levels of GLA and DGLA, which are metabolized to anti-inflammatory compounds, suppress the inflammatory reaction. However, a decrease in these acids’ levels may lead to the development of inflammatory diseases [
 <xref rid="B24-antioxidants-07-00108" ref-type="bibr" class="xref">24</xref>,
 <xref rid="B27-antioxidants-07-00108" ref-type="bibr" class="xref">27</xref>]. In addition, GLA suppresses inflammation mediators such as IL-1β, IL-6, and TNF-α cytokines [
 <xref rid="B12-antioxidants-07-00108" ref-type="bibr" class="xref">12</xref>,
 <xref rid="B28-antioxidants-07-00108" ref-type="bibr" class="xref">28</xref>]. In contrast, 15-HETrE acid, which is a product of the oxidation of dihomo-γ-linolenic acid by 15-LOX, has the ability to inhibit the synthesis of series 4 leukotrienes, whose elevated levels cause intensified pathological cell hyperproliferation [
 <xref rid="B24-antioxidants-07-00108" ref-type="bibr" class="xref">24</xref>]. This contributes to the inhibition of the pro-inflammatory action of leukotrienes, which are involved, among others, in the development of asthma [
 <xref rid="B24-antioxidants-07-00108" ref-type="bibr" class="xref">24</xref>,
 <xref rid="B29-antioxidants-07-00108" ref-type="bibr" class="xref">29</xref>] (see 
 <xref ref-type="fig" rid="antioxidants-07-00108-f001" class="xref">Figure 1</xref>).
</p>
